Elranatamab: Clinical Trials

2 trials of Elranatamab, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting, 1 recruiting. 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 42Not yet recruiting 1, Recruiting 1

Follow Elranatamab: new trials by email Literature Review of Elranatamab trials Research Report on Elranatamab

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase IV Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma That is Not Responding to Four or More Standard Treatments or Has Come Back After Several Standard Treatments
Elranatamab - Relapsed/Refractory Multiple Myeloma, Multiple Myeloma
Phase 4Not yet recruitingPfizer752026-10-222026-10-19
Elranatamab Post Trial Access Study for Participants With Multiple Myeloma (MM)
Elranatamab - Multiple Myeloma
Phase 4RecruitingPfizer802023-10-032026-07-01

Conditions studied

Multiple Myeloma (2)  ·  Neoplasms, Plasma Cell (1)

Sponsors

Pfizer (2)

Countries

Australia (1)  ·  Canada (1)  ·  China (1)  ·  Japan (1)  ·  Spain (1)  ·  Taiwan (1)  ·  United States (1)

NIH funding

2023 (1)